Submission of compliance certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) regulation, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals has submitted a routine compliance certificate to BSE for the quarter ended 30th September 2025, as required under SEBI's Depository Regulations. The certificate, issued by the company's Registrar and Share Transfer Agent (Maashitla Securities Private Limited), confirms that any securities received for demat during the quarter were duly processed and confirmed to the depositories. It also certifies that dematerialised share certificates have been cancelled and the depository names substituted in the register of members within the 15-day deadline. The company's ISIN is INE0SJX01015. Signed by Whole Time Director Saili Jayaram More and filed on 17th October 2025.
This is a routine, mandatory housekeeping filing with no material impact on the company's business, financials, or stock price. It simply fulfils a regulatory requirement related to share dematerialisation processes.